Cerbios is one of the front-runners and a recognized partner for the development and manufacturing of Antibody Drug Conjugates (ADCs).
The unique possibility to develop and manufacture your ADC and its components (mAb, toxin /payload, conjugate) in a single site in Lugano brings a tremendous advantage to the speed and quality of the Drug Substance.
Process development and manufacturing of tox and first clinical batches with one sole partner is the real “one-stop-shop” solution to improve effectiveness, without compromise.
We can follow you with the toxin, mAb and conjugation manufacturing from early stage development up to and including commercial supplies.
Cerbios further expands its offer of services being part of PROVEO Alliance, with extended capacity for mAbs (at AGC Bio) and fill- finish services (at Oncotec).